Use of Extracorporeal Therapies to Treat Severe Caffeine Poisoning

Saeko Kohara1,2, Yoshito Kamijo1, Michiko Takai1

  • 1Department of Clinical Toxicology, Saitama Medical University, Saitama, Japan.

Hemodialysis International. International Symposium on Home Hemodialysis
|June 24, 2025
PubMed

Insights

Extracorporeal blood purification, including hemodialysis, is increasingly used for severe caffeine poisoning in Japan. However, this study found no significant difference in patient outcomes, suggesting further research is needed.

Area of Science:

  • Toxicology
  • Nephrology
  • Emergency Medicine

Background:

  • Acute caffeine poisoning is a growing concern, with extracorporeal blood purification being explored as a treatment.
  • Previous reports suggest the efficacy of hemodialysis and other blood purification methods for severe cases.

Purpose of the Study:

  • To retrospectively evaluate the use and outcomes of extracorporeal blood purification in patients with acute caffeine poisoning in Japan over a 6-year period.
  • To compare outcomes between patients treated with and without extracorporeal blood purification.

Main Methods:

  • A retrospective study included 76 patients treated for acute caffeine poisoning between April 2016 and March 2022.
  • Data collected included demographics, caffeine product consumption, clinical findings, treatments, and outcomes.
  • Patients were categorized into blood purification and non-blood purification groups for comparison.

Main Results:

  • The blood purification group (n=22) had significantly higher caffeine intake, pulse rates, respiratory rates, and serum glucose levels, leading to longer hospital stays.
  • Despite a higher percentage of patients undergoing blood purification in this study compared to a previous one, no statistically significant difference in prognosis was observed.
  • Clinical features and outcomes were similar between this study and a previous related study.

Conclusions:

  • The use of extracorporeal blood purification for caffeine poisoning is increasing in Japan, often based on ingested dose or vital signs rather than serum levels.
  • Current evidence does not definitively confirm improved prognoses with extracorporeal blood purification in severe caffeine poisoning.
  • Further research is required to establish the definitive benefits of extracorporeal blood purification for severe caffeine poisoning.
Abstract

Related Concept Videos

Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
934
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
588
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.0K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
84
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.8K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
39